Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats
Abstract:Glucose infusion in rats for 1-4 days results in insulin resistance and increased triglyceride, whole tissue long-chain fatty acyl-CoA (LCA-CoA), and malonyl-CoA content in red skeletal muscle. Despite this, the relation between these alterations and the onset of insulin resistance has not been defined. We aimed to 1) identify whether the changes in these lipids and of diacylglycerol (DAG) precede or accompany the onset of insulin resistance in glucose-infused rats, 2) determine whether the insulin resistance … Show more
“…Furthermore, it was demonstrated recently that altered expression or activity of AMPK might play a key role in the onset of both high-fat and high-glucose induced insulin resistance (Kraegen et al, 2006;Liu et al, 2006). In the present study, we demonstrated AMPK might also participate in aging-related fat oxidation insufficiency and insulin resistance.…”
Section: Discussionsupporting
confidence: 70%
“…Recently, Kraegen EW and colleagues reported that four days of glucose infusion induced a significant decrement of AMPK activities in rats' muscles and liver, accompanied with impaired insulin signaling and glucose disposal, indicating a possible role of AMPK in glucotoxicity (Kraegen et al, 2006). Our previous study also demonstrated that impaired expression and activity of AMPK, and accordingly insufficient intracellular fatty acid oxidation, might also participate in high-fat associated insulin resistance (lipotoxicity) (Liu et al, 2006).…”
Insufficient intracellular fat oxidation is an important contributor to aging-related insulin resistance, while the precise mechanism underlying is unclear. AMP-activated protein kinase (AMPK) is an important regulator of intracellular fat oxidation and was evidenced to play a key role in high-glucose and high-fat induced glucose intolerance. In the present study, we investigated whether altered AMPK expression or activity was also involved in aging-related insulin resistance. Insulin sensitivity of rats' skeletal muscles was evaluated using in-vitro glucose uptake assay. Activity of α subunit of AMPK (AMPKα ) was evaluated by measuring the phosphorylation of both AMPKα (P-AMPKα ) and acetyl-CoA carboxylase (P-ACC), while expression of AMPKα was assessed by determining the mRNA levels of AMPKα 1 and AMPKα 2, and protein contents of AMPKα . Compared with 4-month old rats, 24-month old rats exhibited obviously impaired insulin sensitivity. At the same time, AMPKα activity significantly decreased, while AMPKα expression did not alter during aging. Glucose transporter 4 expression also decreased in old rats. Compared with 24-month old rats, administration of the specific activator of AMPK, 5-aminoimidazole-4-carboxamide riboside (AICAR), significantly elevated AMPKα activity and GluT4 expression. Also, aging-related insulin resistance was significantly ameliorated by AICAR treatment. In conclusion, aging-related insulin resistance is associated with impaired AMPKα activity and could be ameliorated by AICAR, thus indicating a possible role of AMPK in aging-induced insulin resistance.
“…Furthermore, it was demonstrated recently that altered expression or activity of AMPK might play a key role in the onset of both high-fat and high-glucose induced insulin resistance (Kraegen et al, 2006;Liu et al, 2006). In the present study, we demonstrated AMPK might also participate in aging-related fat oxidation insufficiency and insulin resistance.…”
Section: Discussionsupporting
confidence: 70%
“…Recently, Kraegen EW and colleagues reported that four days of glucose infusion induced a significant decrement of AMPK activities in rats' muscles and liver, accompanied with impaired insulin signaling and glucose disposal, indicating a possible role of AMPK in glucotoxicity (Kraegen et al, 2006). Our previous study also demonstrated that impaired expression and activity of AMPK, and accordingly insufficient intracellular fatty acid oxidation, might also participate in high-fat associated insulin resistance (lipotoxicity) (Liu et al, 2006).…”
Insufficient intracellular fat oxidation is an important contributor to aging-related insulin resistance, while the precise mechanism underlying is unclear. AMP-activated protein kinase (AMPK) is an important regulator of intracellular fat oxidation and was evidenced to play a key role in high-glucose and high-fat induced glucose intolerance. In the present study, we investigated whether altered AMPK expression or activity was also involved in aging-related insulin resistance. Insulin sensitivity of rats' skeletal muscles was evaluated using in-vitro glucose uptake assay. Activity of α subunit of AMPK (AMPKα ) was evaluated by measuring the phosphorylation of both AMPKα (P-AMPKα ) and acetyl-CoA carboxylase (P-ACC), while expression of AMPKα was assessed by determining the mRNA levels of AMPKα 1 and AMPKα 2, and protein contents of AMPKα . Compared with 4-month old rats, 24-month old rats exhibited obviously impaired insulin sensitivity. At the same time, AMPKα activity significantly decreased, while AMPKα expression did not alter during aging. Glucose transporter 4 expression also decreased in old rats. Compared with 24-month old rats, administration of the specific activator of AMPK, 5-aminoimidazole-4-carboxamide riboside (AICAR), significantly elevated AMPKα activity and GluT4 expression. Also, aging-related insulin resistance was significantly ameliorated by AICAR treatment. In conclusion, aging-related insulin resistance is associated with impaired AMPKα activity and could be ameliorated by AICAR, thus indicating a possible role of AMPK in aging-induced insulin resistance.
“…Recently, it has been shown that increased FA availability stimulates AMPK activity in skeletal muscle both in vitro and in vivo (10,(24)(25)(26)(27). Likewise, a diminished AMPK phosphorylation in the liver was also supported by previous works showing that TG accumulation in the liver is in association with decreased AMPK activation (27,28). Similarly, our results show that lipid oversupply produced differing effects on AMPK activation in different tissues.…”
The primary objective of this study was to investigate the impact of lipid oversupply on the AMPK pathway in skeletal muscle, liver, and adipose tissue. Male Wistar rats were infused with lipid emulsion (LE) or phosphate-buffered saline for 5 h/day for 6 days. Muscles exposed to LE for 6 days exhibited increased AMPK and acetyl-CoA carboxylase (ACC) phosphorylation, along with a greater association between AMPK and Ca 2+ /calmodulin-dependent protein kinase kinase (CaMKK). No differences in muscle protein phosphatase 2C (PP2C) activity, LKB1 phosphorylation or AMPK and LKB1 association were observed. Muscle ACCβ, and adiponectin receptor 1 (AdipoR1) mRNA levels and PPARγ-co-activator 1α (PGC1α) protein levels were also increased in LE-treated rats. In contrast, AMPK and ACC phosphorylation decreased and PP2C activity increased in rat livers exposed to LE. Hepatic mRNA levels of ACCα, PPARα, AdipoR1, AdipoR2, and sterol regulatory element-binding protein-1c (SREBP1c) were also reduced after LE infusion. In adipose tissue, there was no significant alteration in AMPK or ACC phosphorylation. These results demonstrate that following lipid oversupply the AMPK pathway was enhanced in rat skeletal muscle while diminished in the liver and was unchanged in adipose tissue. CaMKK in skeletal muscle and PP2C in the liver, at least in part, appear to mediate these alterations. Alterations in AMPK pathway in the liver induced metabolic defects associated with lipid oversupply.
“…Quadriceps muscle is mainly constituted by type 2a and 2b fibers, which are mainly glycolytic and have a low capacity for using fatty acids as fuel, a fact that might explain the accumulation of triglycerides in this tissue in 24-month-old rats, which are characterized by increased serum triglyceride concentration (Escrivá et al 1997). As reported by others (Kiens 2006, Kraegen et al 2006, muscle insulin resistance is rather associated with cellular levels of malonyl-CoA, fatty acyl CoA, diacylglycerol, or ceramide, than with triglyceride accumulation. Thus, more experimental work is needed to clarify the differences in mechanism underlying the differences in insulin sensitivity between oxidative and glycolytic muscles with ageing.…”
Insulin resistance develops with ageing in humans and rodents. Here, we have studied the evolution of insulin sensitivity with ageing trying to discriminate the role of adiposity from that of ageing in this process. We performed oral glucose tolerance tests and determined overall and tissue-specific glucose utilization under euglycemic-hyperinsulinemic conditions in 3-, 8-, and 24-month-old rats fed ad libitum, and in 8-and 24-month-old rats after 3 months of calorie restriction. Body composition and adipocytederived cytokines such as leptin, resistin, and adiponectin were analyzed. Overall insulin sensitivity decreases with ageing. Calorie restriction improves global insulin sensitivity in 8-but not in 24-month-old rats. Insulin-stimulated glucose utilization in adipose tissues decreases in 8 months, while in oxidative muscles it reaches significance only in older rats. Calorie restriction restores adipose tissue insulin sensitivity only in 8-month-old rats and no changes are observed in muscles of 24-month-old rats. Resistin and leptin increase with ageing. Food restriction lowers resistin and increases adiponectin in 8-month-old rats and decreases leptin in both ages. Visceral and total fat increase with ageing and decrease after calorie restriction. We conclude that accretion of visceral fat plays a key role in the development of insulin resistance after sexual maturity, which is reversible by calorie restriction. With aging, accumulation of retroperitoneal and total body fat leads to impaired muscle glucose uptake and to a state of insulin resistance that is difficult to reverse.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.